195 related articles for article (PubMed ID: 35751045)
1. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers.
Li GS; Chen G; Liu J; Tang D; Zheng JH; Luo J; Jin MH; Lu HS; Bao CX; Tian J; Deng WS; Fu JW; Feng Y; Zeng NY; Zhou HF; Kong JL
BMC Pulm Med; 2022 Jun; 22(1):246. PubMed ID: 35751045
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer.
Tang YL; Li GS; Li DM; Tang D; Huang JZ; Feng H; He RQ; Huang ZG; Dang YW; Kong JL; Gan TQ; Zhou HF; Zeng JJ; Chen G
BMC Pulm Med; 2022 Aug; 22(1):300. PubMed ID: 35927660
[TBL] [Abstract][Full Text] [Related]
3. CDK6 is a novel predictive and prognosis biomarker correlated with immune infiltrates in multiple human neoplasms, including small cell lung carcinoma.
Li GS; Huang ZG; Li DM; Tang YL; Zheng JH; Yang L; Feng Y; Peng JX; Li JX; Tang YX; Zeng NY; Jin MH; Tian J; Liu J; Zhou HF; Chen G; Chen F
Funct Integr Genomics; 2023 Nov; 23(4):332. PubMed ID: 37950078
[TBL] [Abstract][Full Text] [Related]
4. Downregulated miRNA-22-3p promotes the progression and leads to poor prognosis of hepatocellular carcinoma through targeting CDKN2C.
Kong D; Wang X; Wang X; Wang Z; Wang F
J BUON; 2021; 26(2):409-417. PubMed ID: 34076987
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
6. ITGB4 Serves as an Identification and Prognosis Marker Associated with Immune Infiltration in Small Cell Lung Carcinoma.
Li GS; Huang ZG; He RQ; Zhang W; Tang YX; Liu ZS; Gan XY; Tang D; Li DM; Tang YL; Zhan YT; Dang YW; Zhou HF; Zheng JH; Jin MH; Tian J; Chen G
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37847361
[TBL] [Abstract][Full Text] [Related]
7. Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer.
Tang D; Li GS; Xu RX; Zhu SY; Luo J; Zheng JH; Liu J; Lu HS; Jin MH; Bao CX; Tian J; Deng WS; Zeng NY; Zhou HF; Kong JL; Chen G
J Oncol; 2022; 2022():2010341. PubMed ID: 35356257
[TBL] [Abstract][Full Text] [Related]
8. MMP12 is a Potential Predictive and Prognostic Biomarker of Various Cancers Including Lung Adenocarcinoma.
Li GS; Tang YX; Zhang W; Li JD; Huang HQ; Liu J; Fu ZW; He RQ; Kong JL; Zhou HF; Chen G
Cancer Control; 2024; 31():10732748241235468. PubMed ID: 38410859
[TBL] [Abstract][Full Text] [Related]
9. Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma.
El Naofal M; Kim A; Yon HY; Baity M; Ming Z; Bui-Griffith J; Tang Z; Robinson M; Grubbs EG; Cote GJ; Hu P
Ann Clin Lab Sci; 2017 Sep; 47(5):523-528. PubMed ID: 29066476
[TBL] [Abstract][Full Text] [Related]
10. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer.
Li DM; Li GS; Li JD; Chen F; Huang H; Huang WY; Huang ZG; Dang YW; Tang YL; Tang ZQ; Tang WJ; Chen G; Lu HP
Clin Transl Oncol; 2024 Jun; 26(6):1519-1531. PubMed ID: 38206516
[TBL] [Abstract][Full Text] [Related]
12. SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer.
Hou W; Li GS; Gao L; Lu HP; Zhou HF; Kong JL; Chen G; Xia S; Wei HY
BMC Med Genomics; 2022 May; 15(1):114. PubMed ID: 35581615
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
14. BCAT1: A risk factor in multiple cancers based on a pan-cancer analysis.
Li GS; Huang HQ; Liang Y; Pang QY; Sun HJ; Huang ZG; Dang YW; Yang LJ; Chen G
Cancer Med; 2022 Mar; 11(5):1396-1412. PubMed ID: 34984849
[TBL] [Abstract][Full Text] [Related]
15. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
17. CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage?
Pereira MJ; Vranic M; Kamble PG; Jernow H; Kristófi R; Holbikova E; Skrtic S; Kullberg J; Svensson MK; Hetty S; Eriksson JW
Transl Res; 2022 Apr; 242():105-121. PubMed ID: 34896253
[TBL] [Abstract][Full Text] [Related]
18. Construction of Prognostic Risk Model for Small Cell Lung Cancer Based on Immune-Related Genes.
Deng F; Tao F; Xu Z; Zhou J; Gong X; Zhang R
Comput Math Methods Med; 2022; 2022():7116080. PubMed ID: 36245844
[TBL] [Abstract][Full Text] [Related]
19. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.
Grubbs EG; Williams MD; Scheet P; Vattathil S; Perrier ND; Lee JE; Gagel RF; Hai T; Feng L; Cabanillas ME; Cote GJ
Thyroid; 2016 Nov; 26(11):1553-1562. PubMed ID: 27610696
[TBL] [Abstract][Full Text] [Related]
20. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma.
Maxwell JE; Gule-Monroe MK; Subbiah V; Hu M; Perrier ND; Cabanillas ME; Lee JE; Graham PH; Cote GJ; Busaidy NL; Grubbs EG
Surgery; 2020 Jan; 167(1):80-86. PubMed ID: 31648931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
